Dhampur Bio Organics shareholders approve dividend, CEO redesignation at AGM
Dhampur Bio Organics Limited concluded its 6th AGM with unanimous promoter support for all resolutions, including a ₹1.50 dividend and leadership restructuring. The meeting addressed financial statements, auditor appointments, and governance amendments, reflecting strong shareholder alignment despite minor public dissent on specific structural changes.

*this image is generated using AI for illustrative purposes only.
Dhampur Bio Organics Limited shareholders approved a final dividend of ₹1.50 per equity share and re-designated Gautam Goel as Chairman and CEO during its 6th Annual General Meeting held on July 24, 2026. The meeting, conducted via video conferencing, saw the passage of all 11 resolutions with overwhelming support from promoter groups, solidifying governance changes following the slump sale of the Meerganj unit.
The meeting commenced at 4:00 PM IST with a quorum present through virtual attendance. Saket Sharma of M/s GSK & Associates served as the scrutinizer, submitting his consolidated report on July 25, 2026. The statutory auditors, M/s Mittal Gupta & Company, were re-appointed for a second five-year term. Remote e-voting was active from July 20 to July 23, 2026, while e-voting at the AGM allowed additional participation for those who had not voted remotely.
Key Resolutions Passed
Shareholders voted on four ordinary business items and seven special business items. All resolutions received majority approval, driven by near-unanimous support from the promoter group.
| Resolution Type | Particulars | Status |
|---|---|---|
| Ordinary | Adoption of Audited Financial Statements for FY26 | Passed |
| Ordinary | Declaration of final dividend @15% (₹1.50 per share) | Passed |
| Ordinary | Re-appointment of Gautam Goel as Director | Passed |
| Ordinary | Re-appointment of Statutory Auditors for 5 years | Passed |
| Special | Amendment of Articles of Association (Article 125A) | Passed |
| Special | Re-designation of Gautam Goel as Chairman and CEO | Passed |
| Special | Amendment in gratuity payment terms for Directors | Passed |
| Ordinary | Revision in remuneration of Maayashree Goel | Passed |
| Ordinary | Revision in remuneration of Meerashree Goel | Passed |
| Special | Payment of Commission to Non-Executive Directors | Passed |
| Ordinary | Ratification of Cost Auditor remuneration for FY27 | Passed |
Voting Analysis
Promoter and Promoter Group shareholders, holding 33,714,207 shares, cast 99.74% of their eligible votes. They voted in favor of all resolutions except for the re-appointment of Gautam Goel by rotation and his re-designation as CEO, where participation was lower but still resulted in unanimous support among votes cast. Public non-institutional shareholders showed dissent on specific governance changes; approximately 4.27% voted against the AOA amendment, while 4.54% opposed the CEO re-designation. However, these dissenting votes did not impact the passage of any resolution.
Governance Updates
The special resolution to amend the Articles of Association by inserting new Article 125A passed with 99.99% support. Additionally, shareholders approved amendments to the terms of gratuity payment to directors, which received 99.86% support. The remuneration revisions for General Managers Maayashree Goel and Meerashree Goel were also approved, each garnering 99.89% support. The company ratified the payment of commission to non-executive directors for FY26, passing with 99.99% approval.
Historical Stock Returns for Dhampur Bio Organics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.29% | +11.37% | +21.99% | +34.35% | +44.49% | -21.98% |
How will the integration of the Meerganj unit post-slump sale impact Dhampur Bio Organics' operational efficiency and EBITDA margins in FY27?
What is the strategic rationale behind the amendment to Article 125A of the Articles of Association, and how might it alter future corporate governance structures?
Given the revision in remuneration for General Managers Maayashree Goel and Meerashree Goel, what specific performance metrics or expansion targets are expected to justify these increases?

































